Clinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement

INTRODUCTION: The rearrangement of the anaplastic lymphoma kinase (ALK) gene accounts for approximately 1%–6% of lung adenocarcinoma cases and defines a molecular subgroup of tumors characterized by clinical sensitivity to ALK inhibitors such as crizotinib. This study aimed to identify the relations...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Sha, Wang, Hai-Yun, Wang, Fang, Huang, Ma-Yan, Deng, Ling, Zhang, Xiao, Ye, Zu-Lu, Shao, Jian-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593362/
https://www.ncbi.nlm.nih.gov/pubmed/26253541
http://dx.doi.org/10.1186/s40880-015-0032-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593362/
https://www.ncbi.nlm.nih.gov/pubmed/26253541
http://dx.doi.org/10.1186/s40880-015-0032-8

Ejemplares similares